Work

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: British Journal of Dermatology

DOI: 10.1111/bjd.12112

Authors: P. Rich, B. Sigurgeirsson, D. Thaci, J.-P. Ortonne, C. Paul, R.E. Schopf, A. Morita, K. Roseau, E. Harfst, A. Guettner, M. Machacek, C. Papavassilis

Institutions: Oregon Health & Science University, University of Iceland, Goethe University Frankfurt, Centre Hospitalier Universitaire de Nice, Hôpital l'Archet, Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier, Johannes Gutenberg University Mainz, Nagoya City University, Novartis (Switzerland)

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Novartis, Les Laboratories Pierre Fabre, Novartis Pharma

OpenAlex ID: W2151209321

FWCI: 19.75

Cites: 25

Cited by: 246

Related to: 10